Investors & Media

Investors & Media

About Kiniksa

Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines designed to modulate immunological signaling pathways for patients suffering from debilitating diseases with significant unmet medical need.


Price: Change: Volume:

Apr 26, 2021 6:38 AM EDT

Copyright Nasdaq. Minimum 15 minutes delayed.

Events and Presentations